Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India

International Journal of Cancer

Volumn 130, Issue 1, 2012, Pages 234-240

  Sahasrabuddhe, Vikrant V ^a   Bhosale, Ramesh A ^b   Kavatkar, Anita N ^b   Nagwanshi, Chandraprabha A ^b   Joshi, Smita N ^c   Jenkins, Cathy A ^a   Shepherd, Bryan E ^a   Kelkar, Rohini S ^d   Sahay, Seema ^c   Risbud, Arun R ^c   Vermund, Sten H ^a   Mehendale, Sanjay M ^e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Byramjee Jeejeebhoy Medical College   (India)

^c NATIONAL AIDS RESEARCH INSTITUTE   (India)

^d TATA MEMORIAL HOSPITAL   (India)

^e National Institute of Epidemiology   (India)

Author keywords

cervical cancer; cytology; HIV AIDS; India; screening; visual inspection

Indexed keywords

ACETIC ACID;

ADOLESCENT; ADULT; ARTICLE; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; COLPOSCOPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VISUAL INSPECTION AFTER APPLICATION OF DILUTE ACETIC ACID ON THE CERVIX; WART VIRUS;

ACETIC ACIDS; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; CROSS-SECTIONAL STUDIES; CYTODIAGNOSIS; DNA, VIRAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; INDIA; MASS SCREENING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 80055046492     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25971     Document Type: Article

References (25)

1. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-94.
2. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
3. Diaz M, Kim JJ, Albero G, de Sanjose S, Clifford G, Bosch FX, Goldie SJ,. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer 2008; 99: 230-8.
4. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
5. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9: 929-36.
6. Schiffman M, Wacholder S,. From India to the world-a better way to prevent cervical cancer. N Engl J Med 2009; 360: 1453-5.
7. Palefsky J,. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 2009; 4: 52-6.
8. Arora P, Kumar R, Bhattacharya M, Nagelkerke NJ, Jha P,. Trends in HIV incidence in India from 2000 to 2007. Lancet 2008; 372: 289-90. (Pubitemid 352020431)
9. Denny L,. Prevention of cervical cancer. Reprod Health Matters 2008; 16: 18-31.
10. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S,. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 2005; 89 (Suppl 2): S4-S12. (Pubitemid 40488754)
11. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, Fayette JM, Cherian J,. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007; 370: 398-406. (Pubitemid 47176655)
12. Akinwuntan AL, Adesina OA, Okolo CA, Oluwasola OA, Oladokun A, Ifemeje AA, Adewole IF,. Correlation of cervical cytology and visual inspection with acetic acid in HIV-positive women. J Obstet Gynaecol 2008; 28: 638-41.
13. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC, Jr,. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005; 294: 2173-81. (Pubitemid 41571134)
14. Kuhn L, Wang C, Tsai WY, Wright TC, Denny L,. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women. AIDS 2010; 24: 2553-61.
15. Sahasrabuddhe VV, Bhosale RA, Joshi SN, Kavatkar AN, Nagwanshi CA, Kelkar RS, Jenkins CA, Shepherd BE, Sahay S, Risbud AR, Vermund SH, Mehendale SM,. Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One 2010; 5: e8634.
16. Sankaranarayanan R, Wesley RS,; International Agency for Research on Cancer. A practical manual on visual screening for cervical neoplasiaed. Lyon: International Agency for Research on Cancer, World Health Organization, 2003.
17. McKenzie DP, Vida S, Mackinnon AJ, Onghena P, Clarke DM,. Accurate confidence intervals for measures of test performance. Psychiatry Res 1997; 69: 207-9. (Pubitemid 27146350)
18. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB,. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132: 810-19. (Pubitemid 30317797)
19. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T,. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119: 1095-101. (Pubitemid 44116919)
20. Sankaranarayanan R, Boffetta P,. Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol 2010; 21: 1935-43.
21. Sherris J, Wittet S, Kleine A, Sellors J, Luciani S, Sankaranarayanan R, Barone MA,. Evidence-based, alternative cervical cancer screening approaches in low-resource settings. Int Perspect Sex Reprod Health 2009; 35: 147-54.
22. Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, Sharma R, Dolo A, Shastri SS, Nacoulma M, Nayama M, Somanathan T, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer 2004; 110: 907-13. (Pubitemid 38758519)
23. Nene B, Jayant K, Arrossi S, Shastri S, Budukh A, Hingmire S, Muwonge R, Malvi S, Dinshaw K, Sankaranarayanan R,. Determinants of womens participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ 2007; 85: 264-72. (Pubitemid 46556725)
24. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP,. Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS 2009; 23: N1-N5.
25. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ,. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008; 26 (Suppl 10): K29-K41.